Glucose intolerance and insulin resistance with aging--studies on insulin receptors and post-receptor events. 1987

T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy

The oral glucose tolerance test and immune reactive insulin level determination were performed on 100 non-obese healthy elderly and 40 young and middle-aged non-obese healthy subjects. In about 60% of the elderly an altered glucose tolerance test was found, but the insulin level was increased in the whole group of elderly subjects. This means an insulin-resistant state with aging. Further investigations were carried out to determine some possible causes of this insulin resistance. The chromium level in sera and granulocytes of elderly was significantly decreased as well as the insulin receptor numbers and the affinity to erythrocytes. In contrast, when the cyclic nucleotide levels were investigated in granulocytes under in vitro stimulation, an age-dependent increase of cAMP level was found and an unresponsiveness of cGMP, which ranged between mild and severe degrees. Concomitantly, all these changes found could contribute to the insulin resistance at the receptor and post-receptor levels with aging.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009712 Nucleotides, Cyclic Cyclic Nucleotide,Cyclic Nucleotides,Nucleotide, Cyclic
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
November 2016, Antioxidants (Basel, Switzerland),
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
October 2013, Age (Dordrecht, Netherlands),
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
February 2013, Aging cell,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
January 1987, Acta medica Scandinavica,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
November 1977, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
June 1989, American journal of hypertension,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
August 1969, Archives of internal medicine,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
July 2003, Respiratory physiology & neurobiology,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
January 1981, Diabetes care,
T Fülöp, and J T Nagy, and I Worum, and G Fóris, and K Mudri, and P Varga, and M Udvardy
December 1980, Hepato-gastroenterology,
Copied contents to your clipboard!